Vojta therapy in multiple sclerosis rehabilitation
Vojta therapy improves gait and postural control in multiple sclerosis rehabilitation
We could not find results for this trial
What it found
We found no results in the registry or in papers.
This trial finished 2 years ago. We found no results in the registry or in any paper that cites it.
What it measured
Main measures
Gait analysed using a medical treadmill at baseline, 4, 8 and 16 weeks
Walking and mobility
Other measures (1)
1. Pain assessed with the Visual Analogue Scale at baseline, 4, 8 and 16 weeks 2. Balance and postural control assessed with the Berg Balance Scale (BBS) and the Tinetti Test at baseline, 4, 8 and 16 weeks 3. Postural control measured using the Timed Walking Test and 12-item Multiple Sclerosis Walking Scale at baseline, 4, 8 and 16 weeks
Walking and mobilityPain
Who could take part
Relapsing MS
Show the full criteria
Inclusion criteria
Inclusion: 1. Final diagnosis of MS (by McDonald's criteria) 2. Relapsing-remitting stage of MS 3. Walkability with or without assistance (4.0-6 in Expanded Disability Status Scale [EDSS]) Exclusion: 1. Younger than 18 years old 2. Progressive MS 3. Phase outbreak or outbreak in the 3 months before the study 4. Medication that prevents or limits the performance of the locomotion reflex 5. Non-treated arterial hypertension 6. Cardiopulmonary incompetence 7. Pregnancy 8. Cancer 9. Active infections 10. Hepatitis B and HIV infection 11. Severe articular degeneration, including patients eligible for orthopedic surgery 12. Advanced osteoporosis 13. A history of stroke and Parkinson disease
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
Background and study aims Multiple sclerosis (MS) is one of the most common causes of neurological disability that affects young adults. It is a lifelong condition that affects the brain and nerves. Gait and balance problems are one of the most common symptoms of the disease even in the early stages, affecting more than 75% of people with MS. These problems affec gait, with a great risk of falling, and also affect most daily life activities, with a great impact on quality of life. Therefore, attention to this problem has to be taken as a priority. The aim of this study will be to compare the short- and long term effects of Vojta therapy and standard rehabilitation on gait, balance, postural control and pain. Who can participate? Patients aged 18 years and over with chronic low back pain What does the study involve? Participants will be randomly allocated to receive Vojta therapy or standard rehabilitation, 10 times in total. Gait, body balance, muscle pain and postural control will be measured before and after treatment and during follow-up visits 1 and 3 months after the end of the study. What are the possible benefits and risks of participating? Participants will receive a complete treatment program, which may lead to improved gait, body balance and postural control and reduced muscle pain. Risks include temporary fatigue up to 24 hours after the first exercise procedures. Where is the study run from? 1. University of Opole (Poland) 2. Malgorzata Fuchs Fizjoterapia (Opole) When is the study starting and how long is it expected to run for? August 2021 to December 2023 Who is the main contact? 1. Lukasz Argier, PT, MSc argier@o2.pl 2. Prof. Jakub Taradaj j.taradaj@awf.katowice.pl
Loading reviews and guidelines…
History
Started
Mar 2022
Finished
Dec 2023